Alkaptonuria: New hope for treatment of rare genetic disease

New hope for treatment of rare genetic disease

(Medical Xpress)—Scientists at the University of Liverpool have found that a drug treatment administered at the earliest signs of a rare genetic disease could prevent the condition from developing in later life.

The disease, called alkaptonuria (AKU), was the first human disorder that was recognised as a genetic disease 100 years ago, but is often mistaken for severe arthritis. Patients with the condition do not have enough of a particular enzyme, leading to a build up of a chemical in the body, which is eliminated in the urine and deposited in the where it is toxic.

Erosion of cartilage

A black pigment, called ochronosis, forms and binds to bone, cartilage and skin, causing the eventual erosion of and the onset of osteoarthritis. As part of a new research programme, Professor Jim Gallagher, Dr Jonathan Jarvis, and Dr Lakshminarayan Ranganath, have improved animal models of how the disease works and found that signs of the condition can appear very early on in life.

The team showed that a drug treatment, called nitisinone, is effective in preventing the onset of the disease if it is used at the earliest signs of the condition, which could appear in the younger years of a patient's life.  They found that if the drug is administered throughout a patient's lifespan it has the potential to completely prevent joint disease.

Professor Jim Gallagher, from the University's Institute of Ageing and Chronic Disease, said: "These findings are not only significant for patients with AKU, but could go some way to understanding the driving processes of ageing and more common such as .

Potential therapies

"The availability of a model that shows the early stages of joint pathology can be studied to allow us to screen other potential therapies for AKU.  We have already begun work with international partners to test gene and protein replacement and we are working on the possibilities for novel anti-sense therapies."

The research is published in the journal Annals of the Rheumatic Diseases.

Related Stories

New cases of rare genetic disorder identified

Feb 13, 2012

Scientists at the University of Liverpool, working with international partners, have shown a rare genetic disease, that causes crippling osteoarthritis in the spine and major joints, is far more prevalent worldwide than previously ...

New method could help prevent osteoarthritis

Sep 12, 2011

A new method is set to help doctors diagnose osteoarthritis at such an early stage that it will be possible to delay the progression of the disease by many years, or maybe even stop it entirely.

Scientists discover an epigenetic cause of osteoarthritis

Jul 06, 2012

In what could be a breakthrough in the practical application of epigenetic science, U.K. scientists used human tissue samples to discover that those with osteoarthritis have a signature epigenetic change (DNA methylation) ...

Recommended for you

Prompt diagnosis of psoriatic arthritis crucial

Oct 24, 2014

Research led by Conway Fellow, Professor Oliver FitzGerald in St Vincent's University Hospital shows that a delay of more than 6 months from initial symptoms to a diagnosis of psoriatic arthritis leads to poorer outcomes ...

Mummy remains refute antiquity of ankylosing spondylitis

Oct 20, 2014

Ankylosing spondylitis is a systemic disease that causes inflammation in the spinal joints and was thought to have affected members of the ancient Egyptian royal families. Now a new study published in Arthritis & Rheumatology, a jour ...

User comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.